Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EUropean Pharmacogenetics of AntiCoagulation Therapy (phenprocoumon)
2009-016994-13Phase 4Completed
- Sponsor
- Utrecht University
- Start
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of phenprocoumon in venous thromboembolism (VTE) and Atrial fibrillation (AFib) (2 arms), sponsored by Utrecht University. Primary endpoint: Percent time within therapeutic INR range 2-3 during 12 weeks. Started Dec 2009; status: completed.
02
Drugs
phenprocoumon
03
Conditions
venous thromboembolism (VTE)Atrial fibrillation (AFib)
Beyond the preview
Go deeper on 2009-016994-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016994-13.